PACS GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.03 USD | +2.77% |
|
+6.45% | 0.00% |
| May. 23 | PACS Group to Acquire Operations of 53 Nursing Homes in US | MT |
| May. 15 | Oppenheimer Adjusts PACS Group Price Target to $32 From $31, Maintains Outperform Rating | MT |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 4,577 | - | - |
| Enterprise Value (EV) 1 | 4,668 | 4,448 | 4,169 |
| P/E ratio | 21.3 x | 16.5 x | 14 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.23 x | 1.08 x | 0.97 x |
| EV / Revenue | 1.25 x | 1.04 x | 0.89 x |
| EV / EBITDA | 13.1 x | 9.93 x | 8.05 x |
| EV / FCF | 29.1 x | 20.8 x | 15.7 x |
| FCF Yield | 3.44% | 4.8% | 6.36% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 152,400 | - | - |
| Reference price 2 | 30.03 | 30.03 | 30.03 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 3,730 | 4,257 | 4,706 |
| EBITDA 1 | - | 355.7 | 448.2 | 518.1 |
| EBIT 1 | - | 321.2 | 412.3 | 480.5 |
| Operating Margin | - | 8.61% | 9.69% | 10.21% |
| Earnings before Tax (EBT) 1 | 157.3 | 285.1 | 381.9 | 458.2 |
| Net income 1 | 112.9 | 207.9 | 279 | 330.2 |
| Net margin | - | 5.57% | 6.55% | 7.02% |
| EPS 2 | - | 1.410 | 1.822 | 2.147 |
| Free Cash Flow 1 | - | 160.4 | 213.3 | 265 |
| FCF margin | - | 4.3% | 5.01% | 5.63% |
| FCF Conversion (EBITDA) | - | 45.09% | 47.6% | 51.16% |
| FCF Conversion (Net income) | - | 77.14% | 76.47% | 80.27% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|
| Net sales 1 | 934.7 | 916.5 | 928.6 | 957.8 | 1,055 | 1,041 |
| EBITDA 1 | 88.51 | 86.99 | 85.96 | 96.72 | 108.7 | 110.5 |
| EBIT 1 | 79.96 | 77.62 | 77.63 | 85.96 | 99.92 | 101.5 |
| Operating Margin | 8.55% | 8.47% | 8.36% | 8.98% | 9.47% | 9.75% |
| Earnings before Tax (EBT) 1 | 73.06 | 68.5 | 69.76 | 79.39 | 87.33 | 96.87 |
| Net income 1 | 49.14 | 49.1 | 50.28 | 57.06 | 60.28 | 69.18 |
| Net margin | 5.26% | 5.36% | 5.41% | 5.96% | 5.71% | 6.64% |
| EPS 2 | 0.3800 | 0.3250 | 0.3300 | 0.3750 | 0.4000 | 0.4550 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | 91.3 | - | - |
| Net Cash position 1 | - | - | 129 | 408 |
| Leverage (Debt/EBITDA) | - | 0.2567 x | - | - |
| Free Cash Flow 1 | - | 160 | 213 | 265 |
| ROE (net income / shareholders' equity) | - | 64.6% | 48.3% | 35.7% |
| ROA (Net income/ Total Assets) | - | 5.9% | 7.56% | 7.95% |
| Assets 1 | - | 3,526 | 3,689 | 4,153 |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 51.5 | 58 | 62.1 |
| Capex / Sales | - | 1.38% | 1.36% | 1.32% |
| Announcement Date | 3/13/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
30.03
USD
Average target price
32
USD
Spread / Average Target
+6.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 4.58B | |
| +17.74% | 83.47B | |
| -29.66% | 69.72B | |
| 0.00% | 26.5B | |
| +3.06% | 17.69B | |
| -12.16% | 16.83B | |
| +2.47% | 15.7B | |
| +74.82% | 13.45B | |
| +0.76% | 12.69B | |
| +73.52% | 12.81B |
- Stock Market
- Equities
- PACS Stock
- Financials PACS Group, Inc.
